<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The association of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with auto-<z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune diseases</z:e> and humoral disorders have already been reported </plain></SENT>
<SENT sid="1" pm="."><plain>In this prospective study we tried to estimate type and the frequency of immunological associated diseases among patients affected by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS-METHODS: In this prospective study, auto-<z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune disease</z:e> and humoral <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immunity disorders</z:e> were systematically searched during <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and conversely <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> searched during cytopenia </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> secondary to chemotherapy and the children's <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> were excluded </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> diagnosis was established according to FAB criteria and patients were classified in two groups A or B according to presence (group A) or not (group B) of dysimmune manifestations </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Forty patients(19 males and 21 females, mean age of 56,6 years) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> have been enrolled during this period (group A: 20 patients) </plain></SENT>
<SENT sid="6" pm="."><plain>Associated diseases are following: <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (three), <z:e sem="disease" ids="C0919715" disease_type="Disease or Syndrome" abbrv="">lupus-like syndrome</z:e>(one), sarcoidisis(one), SjogrÃ«n syndrome(one), <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e> (two), <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver diseases</z:e> (three), autoimmune <z:hpo ids='HP_0000820'>thyroid diseases</z:hpo> (two), <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum (one), <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>(one), <z:hpo ids='HP_0001878'>haemolytic anaemia</z:hpo> (one), and <z:hpo ids='HP_0001698'>pericardial effusion</z:hpo>(one) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: A wide spectrum of auto-immune manifestations is frequently reported in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Further studies are necessary for discuss the current physiopathological hypothesis with their therapeutic relevance </plain></SENT>
</text></document>